1. Home
  2. PXLW vs CVM Comparison

PXLW vs CVM Comparison

Compare PXLW & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PXLW
  • CVM
  • Stock Information
  • Founded
  • PXLW 1997
  • CVM 1983
  • Country
  • PXLW United States
  • CVM United States
  • Employees
  • PXLW N/A
  • CVM N/A
  • Industry
  • PXLW Semiconductors
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PXLW Technology
  • CVM Health Care
  • Exchange
  • PXLW Nasdaq
  • CVM Nasdaq
  • Market Cap
  • PXLW 49.1M
  • CVM 40.1M
  • IPO Year
  • PXLW 2000
  • CVM 1987
  • Fundamental
  • Price
  • PXLW $0.81
  • CVM $0.40
  • Analyst Decision
  • PXLW Strong Buy
  • CVM
  • Analyst Count
  • PXLW 3
  • CVM 0
  • Target Price
  • PXLW $2.17
  • CVM N/A
  • AVG Volume (30 Days)
  • PXLW 349.9K
  • CVM 1.2M
  • Earning Date
  • PXLW 02-12-2025
  • CVM 02-14-2025
  • Dividend Yield
  • PXLW N/A
  • CVM N/A
  • EPS Growth
  • PXLW N/A
  • CVM N/A
  • EPS
  • PXLW N/A
  • CVM N/A
  • Revenue
  • PXLW $43,206,000.00
  • CVM N/A
  • Revenue This Year
  • PXLW $10.25
  • CVM N/A
  • Revenue Next Year
  • PXLW $39.19
  • CVM N/A
  • P/E Ratio
  • PXLW N/A
  • CVM N/A
  • Revenue Growth
  • PXLW N/A
  • CVM N/A
  • 52 Week Low
  • PXLW $0.61
  • CVM $0.33
  • 52 Week High
  • PXLW $3.08
  • CVM $2.50
  • Technical
  • Relative Strength Index (RSI)
  • PXLW 46.76
  • CVM 45.54
  • Support Level
  • PXLW $0.80
  • CVM $0.39
  • Resistance Level
  • PXLW $0.90
  • CVM $0.68
  • Average True Range (ATR)
  • PXLW 0.06
  • CVM 0.06
  • MACD
  • PXLW -0.01
  • CVM 0.01
  • Stochastic Oscillator
  • PXLW 11.96
  • CVM 18.86

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in China.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Share on Social Networks: